
AlphaTON Capital Corp. (NASDAQ:ATON) shares are trading higher Wednesday after the company announced a letter of intent to evaluate tokenization of single-indication economics for TT-4 in mesothelioma.
What To Know: AlphaTon’s non-binding letter of intent to evaluate tokenization of single-indication economics for TT-4 is a major step in merging institutional-grade digital asset infrastructure with breakthrough cancer therapeutics, the company said.